top reasons to invest

Invest today in XSurgical to participate to a major improvement in Health Care:

  • We are aiming to take surgical robotics to more hospitals and related patients, enlarging the market well beyond the $15B estimated today 
  • We are developing robots capable of operating in mission-critical environments, capable of saving lives in the battlefield, in earthquakes or even in road accidents

introduction

XSurgical is poised to revolutionize the surgical robotics industry with its open architecture surgical robot.

By allowing third parties to develop their own surgical tools and software applications that can be integrated with the robot, XSurgical is expanding the set of available procedures and aiming to make the system more efficient. This may ultimately increase the speed of penetration of the robot into even more applications and procedures, as surgeons may be able to extend the use of their preferred tools robotically.

The company is providing a Robot Development Kit to third parties, enabling them to design and integrate their own surgical tools and instruments. XSurgical is already developing an extended set of surgical instruments to enable the execution of both minimally invasive and open surgery. With this open architecture approach, XSurgical is creating an ecosystem of relationships who may help bring the latest technologies and advancements to the surgical robotics industry.

XSurgical does not plan to force hospitals to buy only its own tools and devices. Surgeons may be free to continue to use the tools that they like, adding the advanced features in dexterity and precision that surgical robots can actuate. Thereby, XSurgical plans to expand the set of available procedures and make the system more efficient and easier to learn. This may ultimately increase the speed of penetration of the robot into even more applications and procedures.

The company is planning to provide a Robot Development Kit to third parties, enabling them to design and integrate their own surgical tools and instruments. XSurgical is already developing an extended set of surgical instruments to enable the execution of both minimally invasive and open surgery. With this open architecture approach, XSurgical is creating an ecosystem of relationships who may help bring the latest technologies and advancements to the surgical robotics industry.

The need for a surgical robot that can operate in critical environments, such as battlefields and natural disasters, has never been greater. The Department of Defense is actively seeking technologies to provide optimal care directly on the battlefield, and TATRC is funding surgical robotics research for this purpose. The robot is designed to work with unreliable power sources and enhance telecommunications through the use of AI, making it an increasingly popular choice for mobile operating room units and smaller regional hospitals. With its surgical robot capable of operating both in hospitals and in the field, XSurgical is at the forefront of this important area of research and development.

problem

XSurgical strives to address several problems in the field of surgical robotics.

One of the main problems is that current surgical robots are not cost-effective and do not serve the needs of smaller/regional hospitals, which are unable to provide an adequate flow of patients requiring the same procedure to keep the robot operative full time. This makes it difficult for these hospitals to justify the high cost of purchasing and maintaining a surgical robot.

Another problem is the limited range of procedures that can be performed by current surgical robots, as they are typically designed for specific types of surgeries and may not be suitable for others. This can limit the number of patients who can benefit from the technology and also restrict the number of procedures that can be performed in a single hospital.

XSurgical's approach aims to address these problems by offering a modular, open architecture surgical robot that can be easily adapted to perform a wider range of procedures, including minimally invasive, orthopedic and open surgery.

By enabling third parties to develop their own surgical tools and software applications that can be driven by the robot, XSurgical aims to rapidly expand the set of available procedures and increase the penetration speed of the robot in even more applications/procedures. This would not only make the technology more accessible to smaller hospitals but also increase its usefulness and versatility in the field of surgical robotics.

solution

XSurgical aims to offer several solutions to address these problems:

  • A universal surgical robot that may be able to operate in both hospitals and the field, integrate both minimally invasive, orthopedic and open surgery procedures, work effectively on soft and hard tissues, and potentially allow surgeons to use their preferred tools and systems on the robot.
  • A surgical robot for critical environments that may be deployed inside tent hospitals, truck trailers, and containers, and may work with unreliable power sources and enhance telecommunications through AI.
  • A shareable surgical robot that may be utilized by smaller and regional hospitals by extending the number and type of procedures that can be executed with the same robot, including not only minimally invasive procedures but also open high-precision surgery and some initial orthopedic procedures.
  • An open architecture surgical robot that may enable third parties to develop their own set of surgical tools, instruments, and software applications that can be driven by the robot, providing greater flexibility and expanding the set of available procedures.

By aiming to offer these solutions, XSurgical is working towards making surgical robotics more cost-effective, efficient, and accessible, thereby improving patient outcomes and increasing the utilization of surgical robots in a variety of environments.

success to date

  • Developed 2 generations of robot.
  • Secured 4 patents for the technology.
  • Raised a total of approximately $6 million.

    – More than $6M has been deployed in XSurgical through funds received by Founders, Regional Venture Capital Funds, R&D grants and low interest loans. We have been able to develop three generations of surgical robots with a capital expenditure which is much lower than our competitors required to develop their first prototype.
  • Created the initial prototype of the third generation, which is planned to be released on the market.

    – Our Gamma version is XSurgical’s third generation prototype. Our Alpha and Beta versions were designed for abdominal surgery, working only soft tissues. Alpha was successfully tested on animals for the resection of the pancreatic tail. Alpha was initially conceived to fit on spacecrafts and thus designed to be very small in size. Beta was an enlarged version of Alpha, capable of working on the four quadrants of the abdomen and was successfully CE marked for utilization in Europe. In order to arrive at a universal robotic platform we are developing Gamma in order to enable surgeons to use the same robots to operate on the entire body. Gamma is designed to be at ease with both soft tissues (such as the abdomen) and hard tissues (such as bones) enabling hospitals to invest in a single platform that can be better utilized across various departments.

business model

XSurgical plans to offer several business models to potentially provide sustainable solutions to the problems faced by hospitals in implementing surgical robotics:

  • Robot sales – Hospitals can purchase the surgical robot and integrate it into their existing surgical infrastructure, thus benefiting from its various features such as open architecture and teleoperation.
  • Service maintenance programs – these have the potential to ensure that the robot remains in optimal working condition. These programs include regular maintenance and upgrades to ensure that the robot continues to provide high-quality surgical procedures.
  • Surgical instruments and other disposable parts necessary for the execution of surgical procedures – these are designed to ensure that hospitals have a reliable source of high-quality surgical instruments that are specifically designed to work with XSurgical’s surgical robot.
  • Third-party royalties – for instruments and software development. This business model is designed to enable third parties to design and integrate novel surgical tools and instruments that can be guided through XSurgical’s surgeon console. This may enable the robot to be used for a wider range of surgical procedures and means that XSurgical could remain at the forefront of surgical robotics technology.

Overall, these business models are designed to provide sustainable solutions for hospitals to integrate surgical robotics technology into their existing infrastructure and provide patients with high-quality surgical procedures.

market

The market size related to the existing products on the market is estimated to be in the order of $15-20B per year (2022). Our market is considerably bigger considering that we are targeting smaller hospitals (which is one order magnitude larger than targeted by our competitors worldwide) and we are also targeting disaster recovery/war zones scenarios with mobile units.

team

Dr. Gianluca De Novi
Co-Founder and CEO
Dr. Gianluca De Novi is a highly experienced engineer and scientist with expertise in robotics and control systems. As a faculty member at Harvard Medical School and Harvard Extension School, he has worked on cutting-edge technologies for graphic rendering and virtual reality frameworks optimized for robotic surgery. Dr. De Novi has also acted as a scientific consultant to many leading corporations and research institutions, and he currently serves as a scientific and strategic advisor at ADM Tronics Unlimited Inc. He has been recognized as one of the ten most distinguished Italian professionals in the United States under the age of 40 by the PrimiDieci Society and the Italy-America Chamber of Commerce.
Michele Marzola
Chairman of the Board
Michele Marzola, Chairman of the Board at XSurgical, is an experienced investor and a co-founder and CEO of Interceptin srl in Firenze, Italy. He has facilitated over 20 start-up companies in the life sciences, digital, and professional services industries and has administered activities in major Western and emerging markets. With over 35 years of experience, he has worked in the areas of energy, machinery, raw materials, process industries, services, and information technology. Marzola holds an MBA from Columbia Graduate School of Business and a doctorate in mechanical engineering from the University of Bologna.
Debora Botturi
Co-Founder and Chief Scientific Officer
Debora Botturi holds a master's degree in computer science and a Ph.D. in Robotics from the University of Verona. As an accredited consultant to the European Commission, she has extensive experience in research and supervision of research projects in the areas of robotics and teleoperations, with a particular focus on the application domain of robotic surgery. She co-founded a medical device company and served as Chief Technical Officer and Director of Clinical Affairs before transitioning to technology transfer projects in system automation.

Use of Proceeds


If the offering's maximum amount of $540,000 is raised:

UseValue% of Proceeds
Compensation for managers$53,0009.8%
Product DevelopmentExpense name$220,00040.7%
Intellectual PropertyExpense name$180,00033.3%
Audit Expense name$15,0002.8%
Business DevelopmentExpense name$25,0004.6%
General & Admin.$20,5403.8%
Intermediary fees$26,4604.9%

Terms

This number includes all funds raised by the Company in this round on Netcapital. This is an offering of Common Stock, under registration exemption 4(a)(6), in XSurgical Inc.. This offering must reach its target of at least $10,000 by its offering deadline of October 13, 2023 at 9:59pm ET. If this offering does not reach its target by the offering deadline, then your money will be refunded.

If the offering is successful at raising the maximum amount, then the company’s implied valuation after the offering (sometimes called its post-money valuation) will be:

5,381,407 shares
×
$2 per share
$10,762,814implied valuation

Financials

These financial statements have been reviewed by an independent Certified Public Accountant.

CPA review letter

SEC Filings

The Offering Statement is a formal description of the company and this transaction. It’s filed with the SEC to comply with the requirements of exemption 4(a)(6) of the Securities Act of 1933.

We’re also required to share links to each of the SEC filings related to this offering with investors.

Understand the Risks

Be sure to understand the risks of this type of investment. No regulatory body (not the SEC, not any state regulator) has passed upon the merits of or given its approval to the securities, the terms of the offering, or the accuracy or completeness of any offering materials or information posted herein. That’s typical for Regulation CF offerings like this one.

Neither Netcapital nor any of its directors, officers, employees, representatives, affiliates, or agents shall have any liability whatsoever arising from any error or incompleteness of fact or opinion in, or lack of care in the preparation or publication of, the materials and communication herein or the terms or valuation of any securities offering.

The information contained herein includes forward-looking statements. These statements relate to future events or to future financial performance, and involve known and unknown risks, uncertainties, and other factors, that may cause actual results to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties, and other factors, which are, in some cases, beyond the company’s control and which could, and likely will, materially affect actual results, levels of activity, performance, or achievements. Any forward-looking statement reflects the current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. No obligation exists to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

More Info

Updates

  • Dec 22, 2023
    Filed Form C-U
  • Oct 14, 2023
    Primary offering finalized, selling 7,986 shares
    Sold 7,986 shares at $2 for a total of $15,972
  • Oct 12, 2023
    Greetings from XSurgical! We're democratizing...

    Greetings from XSurgical!

    We’re democratizing surgical robotics by creating a versatile platform that’s accessible to a much larger population worldwide. Our system uses AI and machine learning to perform a range of procedures with precision and accuracy - all while remaining affordable and easily deployable.

    Your investment will contribute to:

    Robot sales: Hospitals can purchase the surgical robot and integrate it into their existing surgical infrastructure. Service maintenance: Potential to ensure that the robot remains in optimal working condition. Surgical instruments: Designed to ensure that hospitals have a reliable source of high-quality surgical instruments specifically designed to work with our surgical robot. Third-party royalties: Enabling third parties to design and integrate novel surgical tools and instruments that can be guided through our surgeon console.

    Warmly, Dr. Gianluca De Novi XSurgical

    Only 24 Hours to Invest! X-Surgical - Less than 24 hours left.jpg
  • Oct 11, 2023
    Greetings from XSurgical! 48 Hours to Invest...

    Greetings from XSurgical!

    48 Hours to Invest in the New Generation of Surgical Robotics!

    We’re democratizing surgical robotics by creating a versatile platform that’s accessible to a much larger population worldwide. Our system uses AI and machine learning to perform a range of procedures with precision and accuracy. (All while remaining affordable and easily deployable).

    Your investment will contribute to:

    Robot sales: Hospitals can purchase the surgical robot and integrate it into their existing surgical infrastructure. Service maintenance: Potential to ensure that the robot remains in optimal working condition. Surgical instruments: Designed to ensure that hospitals have a reliable source of high-quality surgical instruments specifically designed to work with our surgical robot. Third-party royalties: Enabling third parties to design and integrate novel surgical tools and instruments that can be guided through our surgeon console.

    Warmly, Dr. Gianluca De Novi

    Learn More!X-Surgical - 48 hours to Invest.jpg
  • Oct 10, 2023
    Greetings from XSurgical! 3 Days to Invest in...

    Greetings from XSurgical!

    3 Days to Invest in the New Generation of Surgical Robotics!

    Time is running out to invest in the company uniquely positioned to serve the untapped $1.6B opportunity in the Open Field Applications market! (Battlefield, civilian emergencies, robotic ambulances). We’re only accepting investments for 3 more days.

    We’ve opened up a unique investment opportunity to capitalize on our open architecture surgical robot! Cost-effective and reliable in critical environments, we are revolutionizing procedures, expanding possibilities, and improving patient outcomes.

    Successes we’ve seen so far:

    Raised approximately $6M. Developed 2 generations of robots. Secured 4 patents for the technology. Created the initial prototype for our third-generation robot, with plans for commercial release.

    Ready to invest in the surgical robotic market – projected to reach $15B globally? Simply visit our Netcapital raise page.

    Warmly, Dr. Gianluca De Novi

    Learn MoreX-Surgical - 3 Days Left.jpg
  • Oct 6, 2023
    Greetings from XSurgical! Our investment...

    Greetings from XSurgical!

    Our investment window is closing in 1 week!

    We’ve opened up a unique investment opportunity to capitalize on our open architecture surgical robot! Cost-effective and reliable in critical environments, we are revolutionizing procedures, expanding possibilities, and improving patient outcomes.

    Your investment will contribute to:

    Robot sales: Hospitals can purchase the surgical robot and integrate it into their existing surgical infrastructure. Service maintenance: Potential to ensure that the robot remains in optimal working condition. Surgical instruments: Designed to ensure that hospitals have a reliable source of high-quality surgical instruments specifically designed to work with our surgical robot. Third-party royalties: Enabling third parties to design and integrate novel surgical tools and instruments that can be guided through our surgeon console.

    Warmly, Dr. Gianluca De Novi

    Learn More
  • Sep 29, 2023
    This is your last chance to invest in the...

    This is your last chance to invest in the company uniquely positioned to serve the untapped $1.6B opportunity in the Open Field Applications market!

    We are developing mobile operating rooms for smaller hospitals that don’t have access to reliable, modern tech equipment. *This doesn’t include at least another $15B in the normal Regional Hospitals currently neglected by competitors.

    Your investment will contribute to:

    Robot sales: Hospitals can purchase the surgical robot and integrate it into their existing surgical infrastructure. Service maintenance: Potential to ensure that the robot remains in optimal working condition. Surgical instruments: Designed to ensure that hospitals have a reliable source of high-quality surgical instruments specifically designed to work with our surgical robot. Third-party royalties: Enabling third parties to design and integrate novel surgical tools and instruments that can be guided through our surgeon console.

    Warmly, Dr. Gianluca De Novi

    Learn More
  • Sep 26, 2023
    Greetings from XSurgical! We’re on a mission...

    Greetings from XSurgical!

    We’re on a mission to enable access to surgical robotics to a much wider population worldwide. XSurgical’s system is designed to be natively open and teleoperable. This is thanks to AI and machine learning, making it easier to use for more surgeons and more cost-effective for most hospitals!

    Our business models:

    Robot sales: Hospitals can purchase the surgical robot and integrate it into their existing surgical infrastructure, thus benefiting from its various features, such as open architecture and teleoperation.

    Service maintenance programs: Potential to ensure that the robot remains in optimal working condition.

    Third-party royalties: for instruments and software development. This business model is designed to enable third parties to design and integrate novel surgical tools and instruments that can be guided through XSurgical’s surgeon console.

    Our Netcapital campaign is open for a limited time!

    Warmly, Dr. Gianluca De Novi

    Learn MoreXSurgical - Business Model Deep Dive.jpg
  • Sep 22, 2023
    Greetings from XSurgical! Diversify your...

    Greetings from XSurgical!

    Diversify your portfolio today and invest in the new generation of surgical robotics! We are uniquely positioned to serve the untapped $1.6B opportunity in the Open Field Applications market. (Battlefield, civilian emergencies, and robotic ambulances).

    Capitalizing on our open architecture surgical robot!

    By making our robot cost-effective and reliable in critical environments… We are revolutionizing procedures, expanding possibilities, and improving patient outcomes!

    Successes we’ve seen so far:

    Raised approximately $6M. Developed 2 generations of robots. Secured 4 patents for the technology. Created the initial prototype for our third-generation robot, with plans for commercial release.

    Take the leap and invest in the surgical robotic market – which is projected to reach $15B globally. Simply visit our Netcapital raise page. It only takes a few easy steps to become a valued investor.

    Warmly, Dr. Gianluca De Novi

    Learn MoreXSurgical - Successes Date.jpg
  • Sep 20, 2023
    Greetings from XSurgical! We're democratizing...

    Greetings from XSurgical!

    We’re democratizing surgical robotics by creating a versatile platform that’s accessible to a much larger population worldwide. Our system uses AI and machine learning to perform a range of procedures with precision and accuracy, all while remaining affordable and easily deployable.

    Your investment will contribute to:

    Robot sales: Hospitals can purchase the surgical robot and integrate it into their existing surgical infrastructure. Service maintenance: Potential to ensure that the robot remains in optimal working condition. Surgical instruments: Designed to ensure that hospitals have a reliable source of high-quality surgical instruments specifically designed to work with our surgical robot. Third-party royalties: Enabling third parties to design and integrate novel surgical tools and instruments that can be guided through our surgeon console.

    Warmly, Dr. Gianluca De Novi

    Learn MoreJPEG.jpg
  • Sep 5, 2023
    Hello, XSurgical Community! We are developing...

    Hello, XSurgical Community!

    We are developing robots capable of operating in mission-critical environments! They are capable of saving lives on the battlefield, in earthquakes… or even in road accidents!

    Two key points on top reasons to invest:

    Aiming to take surgical robotics to more hospitals and related patients. Enlarge the market well beyond the $15B estimated today.

    Invest in the future of MedTech on Netcapital! With all that we have to offer, we are well-positioned to transform the surgical robot industry as we see it today. Our team has designed a number of perks for our investors.

    Warmly, Dr. Gianluca De Novi

    Learn Morejpeg.jpg
  • Aug 29, 2023
    The XSurgical team was thrilled to connect with...

    The XSurgical team was thrilled to connect with our community on August 24th! For those who missed the online event, catch up with our webinar recap! This is your chance to learn more about how we aim to increase the quality and number of robotic procedures by offering a modular, open-architecture surgical robot.

    Co-founder/CEO Dr. Gianluca De Novi, Chairman of the Board Michele Marzola, and Board of Advisors Arnon Krongrad hosted the online event. We are capitalizing on the surgical robotics market estimated to be in the order of $15-20B annually (2022).

    We discussed how we’re disrupting the market, our innovative technology, where it can be used, and more.

    Traction Highlights:

    Raised approximately $6M. Developed 2 generations of robots. Secured 4 patents for the technology. Created the initial prototype for our third-generation robot, with plans for commercial release. Thank You For Your Time!

    Warmly, Dr. Gianluca De Novi

    Watch NowX-Surgical Webinar Recap Blog Thumbnail.jpg
  • Aug 23, 2023
    Hello, XSurgical Community! This is your last...

    Hello, XSurgical Community!

    This is your last chance to register! Tomorrow at 9:00 AM PST, we’re hosting an exclusive online event. The objective will be to discuss our progress with developing the XSurgical robot, as well as the milestones/traction we have had so far.

    We’re on a mission to increase the quality and number of robotic procedures by offering a modular, open-architecture surgical robot.

    See you soon! Sign up to reserve your spot today. Visit our raise page on Netcapital for more information.

    Warmly, Dr. Gianluca De Novi

    Sign UpJPEG.jpg
  • Aug 21, 2023
    Hello, XSurgical Community! We are in the...

    Hello, XSurgical Community!

    We are in the final days of the registration window! On August 24th 9am PST, we’re hosting an exclusive online event. The objective will be to discuss our progress with developing the XSurgical robot, as well as the milestones/traction we have had so far.

    We’re on a mission to increase the quality and number of robotic procedures by offering a modular, open-architecture surgical robot.

    Hope to see you there! Sign up to reserve your spot today. Visit our raise page on Netcapital for more information.

    Warmly, Dr. Gianluca De Novi

    Sign UpX-Surgical Webinar Promo 3 Day.jpg
  • Aug 17, 2023
    Hello, XSurgical Community! We're on a...

    Hello, XSurgical Community!

    We’re on a mission to increase the quality and number of robotic procedures by offering a modular, open-architecture surgical robot.

    Tune in on August 24th 9am PST. for an exclusive online event. The objective will be to discuss our progress with developing the XSurgical robot, as well as milestones/traction we have had so far.

    Final week to register. Sign up to reserve your spot today. Hope to see you there! Visit our raise page on Netcapital for more information.

    Warmly, Dr. Gianluca De Novi

    Sign Uppic.jpg
  • Aug 14, 2023
    Hello, XSurgical Community! The time is now...

    Hello, XSurgical Community!

    The time is now to take advantage of this unique investment opportunity to capitalize on our open architecture surgical robot! Cost-effective and reliable in critical environments, we are revolutionizing procedures, expanding possibilities, and improving patient outcomes.

    Read our recent blog to learn more about how we’re transforming the surgical robotics industry!

    Warmly, Dr. Gianluca De Novi

    Read MoreBlog X-Surgical - Problem and Solution.jpg
  • Aug 11, 2023
    Hello, XSurgical Community! We're on a...

    Hello, XSurgical Community!

    We’re on a mission to increase the quality and number of robotic procedures by offering a modular, open-architecture surgical robot.

    Tune in on August 24th 9am PST. for an exclusive online event. The objective will be to discuss our progress with developing the XSurgical robot, as well as milestones/traction we have had so far.

    Registration window is open for 2 weeks. Sign up to reserve your spot today. Hope to see you there! Visit our raise page on Netcapital for more information.

    Warmly, Dr. Gianluca De Novi

    Sign UpX.jpg
  • Aug 10, 2023
    Hello, XSurgical Community! Arnon Krongrad,...

    Hello, XSurgical Community!

    Arnon Krongrad, M.D has signed on as our new Board of Advisor! He will serve as a point of interaction with management, investors and Key Opinion Leaders.

    He is also known for his experience in:

    Surgeon: introduced laparoscopic radical prostatectomy, now known as robotic prostatectomy. Entrepreneur: building companies that bring health, food, and biotechnology to market. Researcher: co-authored first study to show cancer prevention w nutritional supplement.

    We’re taking charge by making surgical robotics more abundant in hospitals/related patients. We believe we can enlarge the market well beyond the estimated $15B. Join our community on Netcapital! We’ve raised $6M to date.

    Warmly, Dr. Gianluca De Novi

    Learn More!Arnon.jpg
  • Jul 31, 2023
    Hello, XSurgical Community! Our innovative...

    Hello, XSurgical Community!

    Our innovative team is taking a quantum leap forward with our AI/machine-learning surgical robots! By allowing third parties to actuate robotically their own surgical tools… We’re helping surgeons to assist patients in the best possible way and increasing the utilization of robotic assets.

    We’d like to take this opportunity to highlight the amazing people that have made XSurgical a reality!

    Read our recent blog to learn more.

    Now that you know a little more about who we are and the amazing things we’re striving to accomplish, we hope you will consider joining our investor community of early shareholders!

    Spread the word to your friends, family, and network about joining our investor community on Netcapital today!

    Warmly, Dr. Gianluca De Novi

    Read More
  • Jul 28, 2023
    Hello, XSurgical Community! Our...

    Hello, XSurgical Community!

    Our open-architecture surgical robot is propelling the industry into an era of new possibilities. We’re democratizing surgical robotics by creating a versatile platform accessible to a much broader population.

    What makes this a distinctive addition to the 15 billion-dollar surgical robotics market? Third parties can develop their own surgical tools and software applications. It will expand the range of available procedures, enhancing the efficiency of surgical interventions!

    Providing cost-effectiveness and accessibility: It is capable of operating in hospitals, as well as critical environments such as battlefields and disaster areas.

    Successes we’ve seen so far:

    Raised approximately $6M. Developed 2 generations of robots. Secured 4 patents for the technology. Created the initial prototype for our third-generation robot, with plans for commercial release.

    Warmly, Dr. Gianluca De Novi

    Invest TodayXSurgical - Seize the opportunity.jpg
  • Jul 27, 2023
    Hello, XSurgical Community! Current surgical...

    Hello, XSurgical Community!

    Current surgical robots lack cost-effective options for smaller hospitals/medical field sites. They are difficult for the smaller facilities to justify financially, as they lack the constant influx of patients and procedures to make them affordable. Plus, there is a limited range of procedures that can be performed with these surgical robots.

    Our affordable and easily deployable robots:

    Universal Surgical Robot Surgical Robot for Critical Environments Shareable Surgical Robot Open Architecture Surgical Robot

    If you haven’t already, be sure to read our recent blog to learn more about our solutions to critical challenges!

    Invest in the future of MedTech on Netcapital! With all that we have to offer, we are well-positioned to transform the surgical robot industry as we see it today. Our team has designed a number of perks for our investors.

    Warmly, Dr. Gianluca De Novi Co-Founder and CEO XSurgical

    Learn MoreXSurgical - Offering solutions to critical challenges.jpg
  • Jul 26, 2023
    Hello, XSurgical Community! Watch our webinar...

    Hello, XSurgical Community!

    Watch our webinar recap to learn about how we’re democratizing surgical robotics by creating a versatile platform that’s accessible to a much larger population. Co-Founder/CEO Dr. Gianluca De Novi and Chairman of the Board Michele Marzola hosted the online event!

    You can watch the full webinar recap here.

    Investment Highlights:

    Raised approximately $6M. Developed 2 generations of robots. Secured 4 patents for the technology. Created the initial prototype for our third-generation robot, with plans for commercial release

    Be sure to spread the word and let your friends, family, and network! Ready to take the leap? Take action and join our investor community on Netcapital with tons of exciting perks!

    Warmly, Dr. Gianluca De Novi

    Watch Now
  • Jul 26, 2023
    Filed Form C/A
  • Jul 20, 2023
    Filed Form C/A
  • Jul 10, 2023
    Hello, XSurgical Community! Final...

    Hello, XSurgical Community!

    Final Registration Warning!

    Tomorrow at 11 AM PST, we’re holding an exclusive Q&A webinar. This is your better chance to find out how we’re democratizing surgical robotics by creating a versatile platform accessible to a much larger population worldwide.

    Reserve your spot today

    We’re on a mission to increase the quality and availability of robotic procedures by offering a modular, open-architecture surgical robot. The XSurgical team is excited to see you! (Virtually). Visit our raise page on Netcapital for more information.

    Warmly, Dr. Gianluca De Novi

    Sign Up
  • Jul 7, 2023
    Hello, XSurgical Community! The big day is...

    Hello, XSurgical Community!

    The big day is right around the corner! On July 11th at 11 AM PST, we’re holding an exclusive Q&A webinar. Find out how we’re democratizing surgical robotics by creating a versatile platform designed to serve the Regional Hospitals, serving a much larger population worldwide.

    Final Days of Registration

    We’re on a mission to increase the quality and availability of robotic procedures by offering a modular, open-architecture surgical robot.

    The XSurgical team is excited to see you! (Virtually). Visit our raise page on Netcapital for more information.

    Warmly, Dr. Gianluca De Novi

    Sign Up
  • Jul 6, 2023
    Hello, XSurgical Community! The clock is...

    Hello, XSurgical Community!

    The clock is ticking! On July 11th at 11 AM PST, we’re holding an exclusive Q&A webinar. Find out how we’re democratizing surgical robotics by creating a versatile platform accessible to a much larger population worldwide.

    Registration closes in 5 days.

    We’re on a mission to increase the quality and availability of robotic procedures by offering a modular, open-architecture surgical robot.

    The XSurgical team is excited to see you! (Virtually). Visit our raise page on Netcapital for more information.

    Warmly, Dr. Gianluca De Novi

    Sign Up
  • Jul 3, 2023
    Hello, XSurgical Community! We're on a...

    Hello, XSurgical Community!

    We’re on a mission to increase the quality and availability of robotic procedures by offering a modular, open-architecture surgical robot.

    *Don’t forget that on July 11th at 11 AM PST, we’re holding an exclusive Q&A webinar! Find out how we’re democratizing surgical robotics by creating a versatile platform accessible to a much larger population worldwide.

    Only 1 week left to register. Sign up to reserve your spot today. Hope to see you there! Visit our raise page on Netcapital for more information.

    Warmly, Dr. Gianluca De Novi

    Sign Up
  • Jun 27, 2023
    Hello, XSurgical Community! We're on a...

    Hello, XSurgical Community!

    We’re on a mission to increase the quality and number of robotic procedures by offering a modular, open-architecture surgical robot.

    Tune in on July 11th at 11 AM PST for an exclusive Q&A webinar. Find out how we’re democratizing surgical robotics by creating a versatile platform accessible to anyone worldwide!

    Registration window is open for 2 weeks. Sign up to reserve your spot today. Hope to see you there! Visit our raise page on Netcapital for more information.

    Warmly, Dr. Gianluca De Novi

    Sign Up
  • Jun 22, 2023
    Hello, XSurgical Community! The majority of...

    Hello, XSurgical Community!

    The majority of the global population does not have access to surgical robotics. It’s time we brought this technology to the people! XSurgical is working towards making surgical robotics more cost-effective, efficient, and accessible.

    In addition to creating an affordable, universal surgical robot, we’re opening our architecture, allowing third parties to develop their own surgical tools and software applications.

    Our team is taking proactive measures to improve patient outcomes. By increasing the availability of surgical robots in various environments, we can change the world. We are seeking potential shareholders to take advantage of this medtech investment opportunity.

    Our team has designed a number of perks for our investors. Visit Netcapital and download our pitch deck to learn more about XSurgical and how you can join our investment opportunity.

    Warmly, Dr. Gianluca De Novi

    Learn MoreX Surgical Revolutionizing Surgical Robotics.jpg
  • May 15, 2023
    Primary offering of 270,000 shares at $2
  • May 15, 2023
    Filed Form C

Ask a Question

Proofread your comment before submitting: once it's posted, you can’t edit or delete it. Investors are advised to review our Discussion Board Policy before submitting a comment. For the fastest help with the web site, email help@netcapital.com instead of commenting.

Looking to raise capital?
We can help turn your friends, family and customers into investors.

Learn more

Interested in more investment opportunities?
Browse all offerings currently available.

See more